Skip to content

Maravai LifeSciences

Contact

About
Brands
Impact
- Our Impact
- Maravai Foundation
Insights
Investors
Careers

Home | Insights | TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

April, 2024
Press Release

Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe.

Extraordinary science.
Everyday miracles.

About
Brands
Helpful links

Share price

Connect with us

LinkedIn

Terms
Privacy notice
Site map

© 2024 Maravai LifeSciences. All rights reserved